Liu, Dan-Dan
Luo, Piao
Gu, Liwei
Zhang, Qian
Gao, Peng
Zhu, Yongping
Chen, Xiao
Guo, Qiuyan
Zhang, Junzhe
Ma, Nan
Wang, Jigang http://orcid.org/0000-0002-0575-0105
Funding for this research was provided by:
the fundamental research funds for the central public welfare research institutes (ZXKT18003)
the Major National Science and Technology Program of China for Innovative Drug (2017ZX09101002-001-001-05)
the national key research and development program of china (2020YFA0908000, 2020YFA0908004, 2020YFA0908001)
national natural science foundation of china (81903588, 81803456, 81702580, 82074098, 81841001 and 81803389)
National Natural Science Foundation of China (81903866)
Article History
Received: 13 April 2021
Accepted: 12 July 2021
First Online: 9 August 2021
Declarations
:
: All experiments animal operations meet the requirements of the Beijing Administration Rule of Laboratory Animal and were approved by the Animal Experimental Ethics Review Committee of the Institute of Basic Research for Chinese Medicine, China Academy of Chinese Medical Sciences.
: Not applicable.
: The authors declare that there are no conflicts of interest.